← Back to All US Stocks

BTSGU Stock Analysis - BrightSpring Health Services, Inc. AI Rating

BTSGU Nasdaq Services-Home Health Care Services DE CIK: 0001865782
Recently Updated • Analysis: Mar 21, 2026 • SEC Data: 2025-12-31
AI Rating
HOLD
65% Confidence

📊 BTSGU Key Takeaways

Revenue: $12.9B
Net Margin: 1.5%
Free Cash Flow: $394.7M
Current Ratio: 1.57x
Debt/Equity: 1.34x
EPS: $0.87
AI Rating: HOLD with 65% confidence

Investment Thesis

BrightSpring demonstrates strong revenue growth (+28.2% YoY) and solid cash generation with $394.7M free cash flow, indicating operational execution in home healthcare services. However, thin profitability margins (1.5% net, 2.3% operating) and elevated leverage (1.34x D/E) with weak interest coverage (1.9x) suggest limited financial flexibility and vulnerability to operational disruptions.

BTSGU Strengths

  • + Robust revenue growth of 28.2% YoY demonstrating market demand and expansion
  • + Strong free cash flow generation of $394.7M supporting capital allocation and debt service
  • + Solid current and quick ratios (1.57x and 1.12x) indicating adequate short-term liquidity
  • + Significant improvement in diluted EPS (+1066.7% YoY) showing operational leverage benefits

BTSGU Risks

  • ! Extremely thin net margin of 1.5% and operating margin of 2.3% leave minimal buffer for cost pressures or reimbursement changes
  • ! High leverage with 1.34x D/E ratio and $2.5B long-term debt combined with weak 1.9x interest coverage ratio
  • ! Low ROA (3.0%) and modest ROE (10.2%) relative to debt levels indicate inefficient capital deployment
  • ! Home healthcare sector vulnerability to regulatory reimbursement changes and labor cost inflation

Key Metrics to Watch

BTSGU Financial Metrics

Revenue
$12.9B
Net Income
$190.7M
EPS (Diluted)
$0.87
Free Cash Flow
$394.7M
Total Assets
$6.4B
Cash Position
$88.4M

💡 AI Analyst Insight

The relatively thin 3.1% FCF margin may limit capital allocation flexibility.

BTSGU Profitability Ratios

Gross Margin 11.8%
Operating Margin 2.3%
Net Margin 1.5%
ROE 10.2%
ROA 3.0%
FCF Margin 3.1%

BTSGU vs Default Sector

How BrightSpring Health Services, Inc. compares to Default sector averages

Net Margin
BTSGU 1.5%
vs
Sector Avg 12.0%
BTSGU Sector
ROE
BTSGU 10.2%
vs
Sector Avg 15.0%
BTSGU Sector
Current Ratio
BTSGU 1.6x
vs
Sector Avg 1.8x
BTSGU Sector
Debt/Equity
BTSGU 1.3x
vs
Sector Avg 0.7x
BTSGU Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

BTSGU Balance Sheet & Liquidity

Current Ratio
1.57x
Quick Ratio
1.12x
Debt/Equity
1.34x
Debt/Assets
70.6%
Interest Coverage
1.88x
Long-term Debt
$2.5B

BTSGU 5-Year Financial Trend

BTSGU 5-year financial data: Year 2024: Revenue $11.3B, Net Income -$53.9M, EPS $-0.46. Year 2025: Revenue $12.9B, Net Income -$154.6M, EPS $-1.31.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: BrightSpring Health Services, Inc.'s revenue has grown significantly by 15% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.31 indicates the company is currently unprofitable.

BTSGU Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
3.1%
Free cash flow / Revenue

BTSGU Quarterly Performance

Quarterly financial performance data for BrightSpring Health Services, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $2.6B -$8.2M $-0.04
Q2 2025 $2.4B $19.9M $0.10
Q1 2025 $2.3B $29.5M $0.14
Q3 2024 $2.3B -$8.2M $-0.04
Q2 2024 $2.2B $4.0M $0.03
Q1 2024 $2.0B -$21.4M $-0.18

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

BTSGU Capital Allocation

Operating Cash Flow
$490.2M
Cash generated from operations
Stock Buybacks
$43.2M
Shares repurchased (TTM)
Capital Expenditures
$95.5M
Investment in assets
Dividends
None
No dividend program

BTSGU SEC Filings

Access official SEC EDGAR filings for BrightSpring Health Services, Inc. (CIK: 0001865782)

📋 Recent SEC Filings

Date Form Document Action
Mar 6, 2026 4 xslF345X05/form4.xml View →
Mar 6, 2026 4 xslF345X05/form4.xml View →
Mar 6, 2026 4 xslF345X05/form4.xml View →
Mar 6, 2026 4 xslF345X05/form4.xml View →
Mar 6, 2026 4 xslF345X05/form4.xml View →

Frequently Asked Questions about BTSGU

What is the AI rating for BTSGU?

BrightSpring Health Services, Inc. (BTSGU) has an AI rating of HOLD with 65% confidence, based on fundamental analysis of SEC EDGAR filings.

What are BTSGU's key strengths?

Robust revenue growth of 28.2% YoY demonstrating market demand and expansion. Strong free cash flow generation of $394.7M supporting capital allocation and debt service.

What are the risks of investing in BTSGU?

Extremely thin net margin of 1.5% and operating margin of 2.3% leave minimal buffer for cost pressures or reimbursement changes. High leverage with 1.34x D/E ratio and $2.5B long-term debt combined with weak 1.9x interest coverage ratio.

What is BTSGU's revenue and growth?

BrightSpring Health Services, Inc. reported revenue of $12.9B.

Does BTSGU pay dividends?

BrightSpring Health Services, Inc. does not currently pay dividends.

Where can I find BTSGU SEC filings?

Official SEC filings for BrightSpring Health Services, Inc. (CIK: 0001865782) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is BTSGU's EPS?

BrightSpring Health Services, Inc. has a diluted EPS of $0.87.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 21, 2026 | Data as of: 2025-12-31 | Powered by Claude AI